Skip to content
Screener

Stryker SYK Spine — Net Sales

Other product segments

Trauma and Extremities
$1.04B+9.5%
Instruments
$920M+9.8%
Medical
$902M-4.6%
Endoscopy
$868M+0.1%
Knees
$670M+4.9%
Ortho Tech
$646M
Vascular
$517M+27.3%
Hips
$460M+3.8%

Similar metrics at other companies

POS
POSTNut butters — Net Sales
$101.3M+392%
POS
POSTPet Food — Net Sales
$346.7M-19.9%
Otis Worldwide logo
OTISService sales — Net Sales
$2.58B+11.3%
Central Garden & Pet Company logo
CENTPet — Net Sales
$476.84M+5.1%
Central Garden & Pet Company logo
CENTOther pet products — Net Sales
$164M+7.3%
Corteva logo
CTVAFungicides — Net Sales
$222M+2.8%

Other financials

Income statement

See full
Revenue$6.6B+9.4%
Gross profit$4.5B+17.1%
Operating income$1.7B+49.1%
Net income$1.3B+44.3%
EPS (diluted)$3.30+44.1%

Balance sheet

See full
Cash & equivalents$3.4B+42.8%
Total debt$14.2B-15.2%
Total assets$47.9B+3.5%

Cash flow

See full
Operating cash flow$1.3B+13.5%
CapEx$202.0M+10.4%
Free cash flow$1.1B+14.1%

Valuation

See full
Market cap$124.86B-14.4%
Enterprise value$135.66B-15.3%
P/E33.5×-16.5×
P/S4.8×-1.3×

Profitability

See full
Gross margin65%+0.8pp
Operating margin21.4%+6.2pp
Net margin14.4%+2.2pp
FCF margin18.2%+1.3pp

Returns & leverage

See full
Return on equity32.8%
Debt / equity0.8×
Current ratio2.2×+0.4×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: Stryker’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 11:10 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000310764-26-000031
Net Sales by BusinessThree Months / 2026Three Months / 2025
Orthopaedics:
Knees$670$639
Hips460443
Trauma and Extremities1,035945
Ortho Tech646617
Spinal Implants2166
$2,813$2,810
Total$6,020$5,866

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Stryker's spine — net sales?
Stryker (SYK) reported spine — net sales of $2M in Q1 2026.
How has Stryker's spine — net sales changed year-over-year?
Stryker's spine — net sales decreased by 98.8% year-over-year, from $166M to $2M.
What is the long-term trend for Stryker's spine — net sales?
Over 2 years (2021 to 2025), Stryker's spine — net sales has grown at a -60.2% compound annual growth rate (CAGR), from $1.17B to $185M.
What does spine — net sales mean?
This metric represents the total revenue generated from the sale of spinal implant devices, including hardware and instrumentation used in spinal fusion and deformity correction procedures. It reflects the company's market penetration and competitive positioning within the specialized neurosurgical and orthopedic spine market. As a key growth driver, this segment's performance is sensitive to procedural volumes, surgeon adoption rates, and the introduction of new implant technologies.

Ask your AI about Stryker's spine — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude